192 related articles for article (PubMed ID: 35232250)
21. Control of extracellular dopamine at dendrite and axon terminals.
Ford CP; Gantz SC; Phillips PE; Williams JT
J Neurosci; 2010 May; 30(20):6975-83. PubMed ID: 20484639
[TBL] [Abstract][Full Text] [Related]
22. Cav1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neurons.
Dragicevic E; Poetschke C; Duda J; Schlaudraff F; Lammel S; Schiemann J; Fauler M; Hetzel A; Watanabe M; Lujan R; Malenka RC; Striessnig J; Liss B
Brain; 2014 Aug; 137(Pt 8):2287-302. PubMed ID: 24934288
[TBL] [Abstract][Full Text] [Related]
23. Differential regulation of somatodendritic and nerve terminal dopamine release by serotonergic innervation of substantia nigra.
Cobb WS; Abercrombie ED
J Neurochem; 2003 Feb; 84(3):576-84. PubMed ID: 12558977
[TBL] [Abstract][Full Text] [Related]
24. RIM is essential for stimulated but not spontaneous somatodendritic dopamine release in the midbrain.
Robinson BG; Cai X; Wang J; Bunzow JR; Williams JT; Kaeser PS
Elife; 2019 Sep; 8():. PubMed ID: 31486769
[TBL] [Abstract][Full Text] [Related]
25. Neurochemical characterization of the release and uptake of dopamine in ventral tegmental area and serotonin in substantia nigra of the mouse.
John CE; Budygin EA; Mateo Y; Jones SR
J Neurochem; 2006 Jan; 96(1):267-82. PubMed ID: 16300629
[TBL] [Abstract][Full Text] [Related]
26. Voltage-operated Ca2+ channels regulate dopamine release from somata of dopamine neurons in the substantia nigra pars compacta.
Kim Y; Park MK; Chung S
Biochem Biophys Res Commun; 2008 Sep; 373(4):665-9. PubMed ID: 18601902
[TBL] [Abstract][Full Text] [Related]
27. Immunocytochemical identification of proteins involved in dopamine release from the somatodendritic compartment of nigral dopaminergic neurons.
Witkovsky P; Patel JC; Lee CR; Rice ME
Neuroscience; 2009 Dec; 164(2):488-96. PubMed ID: 19682556
[TBL] [Abstract][Full Text] [Related]
28. Dichotomy of tyrosine hydroxylase and dopamine regulation between somatodendritic and terminal field areas of nigrostriatal and mesoaccumbens pathways.
Salvatore MF; Pruett BS
PLoS One; 2012; 7(1):e29867. PubMed ID: 22242182
[TBL] [Abstract][Full Text] [Related]
29. Heterogeneity of electrically evoked dopamine release and reuptake in substantia nigra, ventral tegmental area, and striatum.
Cragg S; Rice ME; Greenfield SA
J Neurophysiol; 1997 Feb; 77(2):863-73. PubMed ID: 9065855
[TBL] [Abstract][Full Text] [Related]
30. Motor activity-induced dopamine release in the substantia nigra is regulated by muscarinic receptors.
Andersson DR; Björnsson E; Bergquist F; Nissbrandt H
Exp Neurol; 2010 Jan; 221(1):251-9. PubMed ID: 19944096
[TBL] [Abstract][Full Text] [Related]
31. Relative involvement of globus pallidus and subthalamic nucleus in the regulation of somatodendritic dopamine release in substantia nigra is dopamine-dependent.
Cobb WS; Abercrombie ED
Neuroscience; 2003; 119(3):777-86. PubMed ID: 12809698
[TBL] [Abstract][Full Text] [Related]
32. Dopamine-mediated volume transmission in midbrain is regulated by distinct extracellular geometry and uptake.
Cragg SJ; Nicholson C; Kume-Kick J; Tao L; Rice ME
J Neurophysiol; 2001 Apr; 85(4):1761-71. PubMed ID: 11287497
[TBL] [Abstract][Full Text] [Related]
33. Regulation of somatodendritic dopamine release by corticotropin-releasing factor via the inhibition of voltage-operated Ca2+ channels.
Kim Y; Park MK; Chung S
Neurosci Lett; 2009 Nov; 465(1):31-5. PubMed ID: 19729048
[TBL] [Abstract][Full Text] [Related]
34. Is there a significant somatodendritic uptake of dopamine in the substantia nigra? Evidence from the weaver mutant mouse.
Simon JR; Ghetti B
Neurochem Int; 1993 May; 22(5):471-7. PubMed ID: 8485453
[TBL] [Abstract][Full Text] [Related]
35. Selective expression of Parkinson's disease-related Leucine-rich repeat kinase 2 G2019S missense mutation in midbrain dopaminergic neurons impairs dopamine release and dopaminergic gene expression.
Liu G; Sgobio C; Gu X; Sun L; Lin X; Yu J; Parisiadou L; Xie C; Sastry N; Ding J; Lohr KM; Miller GW; Mateo Y; Lovinger DM; Cai H
Hum Mol Genet; 2015 Sep; 24(18):5299-312. PubMed ID: 26123485
[TBL] [Abstract][Full Text] [Related]
36. Dysregulation of Norepinephrine Release in the Absence of Functional Synaptotagmin 7.
Shih AM; Varghese L; Bittar A; Park SH; Chung JM; Shin OH
J Cell Biochem; 2016 Jun; 117(6):1446-53. PubMed ID: 27043247
[TBL] [Abstract][Full Text] [Related]
37. Synaptotagmin-1-dependent phasic axonal dopamine release is dispensable for basic motor behaviors in mice.
Delignat-Lavaud B; Kano J; Ducrot C; Massé I; Mukherjee S; Giguère N; Moquin L; Lévesque C; Burke S; Denis R; Bourque MJ; Tchung A; Rosa-Neto P; Lévesque D; De Beaumont L; Trudeau LÉ
Nat Commun; 2023 Jul; 14(1):4120. PubMed ID: 37433762
[TBL] [Abstract][Full Text] [Related]
38. Allosteric stabilization of calcium and phosphoinositide dual binding engages several synaptotagmins in fast exocytosis.
Kobbersmed JRL; Berns MMM; Ditlevsen S; Sørensen JB; Walter AM
Elife; 2022 Aug; 11():. PubMed ID: 35929728
[TBL] [Abstract][Full Text] [Related]
39. I(h) channels contribute to the different functional properties of identified dopaminergic subpopulations in the midbrain.
Neuhoff H; Neu A; Liss B; Roeper J
J Neurosci; 2002 Feb; 22(4):1290-302. PubMed ID: 11850457
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
